Cross-source evidence timeline

Gallium Ga 68 dotatate research timeline

Follow 13 selected, directly cited source records from June 1, 2016 through October 26, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

13Selected records
6Source years
3Evidence lanes
October 26, 2026Latest source date

Source year

2026

5 records
  1. Clinical trials

    ClinicalTrials.gov record NCT03206060↗

    PeptideScanner retained ClinicalTrials.gov record NCT03206060 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-10-26, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.↗

  2. Literature metadata

    Pulmonary Metastasis of Grade 1 Meningioma Mimicking a Carcinoid Tumor: A Case Report with FDG PET/CT, Ga-68 DOTATATE PET/CT, and Pathological Confirmation.↗

    PubMed lists PMID 42787917 in World journal of nuclear medicine as Case Reports, Journal Article, with publication-date metadata of 2026-05-05 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT07150806↗

    PeptideScanner retained ClinicalTrials.gov record NCT07150806 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-08-13, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT04040088↗

    PeptideScanner retained ClinicalTrials.gov record NCT04040088 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT04069299↗

    PeptideScanner retained ClinicalTrials.gov record NCT04069299 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.↗

Source year

2025

2 records
  1. Clinical trials

    ClinicalTrials.gov record NCT03448458↗

    PeptideScanner retained ClinicalTrials.gov record NCT03448458 at 2026-11-16T17:36:42.191Z. Its registry update date was 2025-07-17, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.↗

  2. Literature metadata

    Incidental Papillary Thyroid Carcinoma Detected by Ga-68 DOTATATE PET/CT: A Rare Case Study and Clinical Considerations.↗

    PubMed lists PMID 38262470 in Nuklearmedizin. Nuclear medicine as Case Reports, Journal Article, with publication-date metadata of 2024-01-23 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2024

3 records
  1. Literature metadata

    Training and assessing convolutional neural network performance in automatic vascular segmentation using Ga-68 DOTATATE PET/CT.↗

    PubMed lists PMID 38967895 in The international journal of cardiovascular imaging as Journal Article, Validation Study, Comparative Study, with publication-date metadata of 2024-07-05 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Time-of-Flight PET/CT Imaging of Ga-68-Dotatate: Normal Pattern, SUV Quantification, and Differences from Non-Time-of-Flight Imaging.↗

    PubMed lists PMID 38933071 in World journal of nuclear medicine as Journal Article, with publication-date metadata of 2024-05-07 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    The lesion detection rate of Ga-68 DOTATATE PET/MR in multiple endocrine neoplasia type 1.↗

    PubMed lists PMID 38563291 in Journal of medical imaging and radiation oncology as Journal Article, with publication-date metadata of 2024-04-02 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2023

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT03953131↗

    PeptideScanner retained ClinicalTrials.gov record NCT03953131 at 2026-11-16T17:36:42.191Z. Its registry update date was 2023-09-01, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.↗

Source year

2021

1 record
  1. Literature metadata

    Doing Great With DOTATATE: Update on GA-68 DOTATATE Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Evaluation of Sinonasal Tumors.↗

    PubMed lists PMID 34096898 in Topics in magnetic resonance imaging : TMRI as Journal Article, Review, with publication-date metadata of 2021-06-01 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2016

1 record
  1. Regulatory

    Drugs@FDA application NDA208547↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 208547 with status AP dated 2016-06-01, and names gallium dotatate ga-68 among the application record's active ingredients.↗